1 / 3

Molecular Diagnostics Market

The prevalence of chronic diseases, infectious diseases, and genetic disorders has also increased significantly. Molecular diagnostics are widely used for the detection of these diseases.

Rachana1
Download Presentation

Molecular Diagnostics Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Future of Molecular Diagnostics MarketHighlighting Regional Revenue Share Dominance by 2031 Molecular Diagnostics Market by Product & Services [Systems & Instruments, Assay Reagents & Kits, and Software & Service], Technology [Polymerase Chain Reaction (PCR), DNA Sequencing & Next-Generation Sequencing (NGS), In Situ Hybridization, and Microarrays], Application [Infectious disease, Oncology, Pharmacogenomics, Genetic Testing], End User [Hospitals, Academic Institutes & Research Centers and Clinical & Pathology Labs] – Global Outlook & Forecast 2021-2031. According to the deep-dive market assessment study conducted by Growth+ Reports, the global molecular diagnostics market was pegged at ~US$ 9.1 billion in 2020. The market is expected to witness a CAGR of ~8.6% from 2021 to 2031. The prevalence of chronic diseases, infectious diseases, and genetic disorders has also increased significantly. Molecular diagnostics are widely used for the detection of these diseases. Furthermore, sudden viral outbreaks of H1N1 & COVID-19 and an increase in its incidence across the globe have raised the demand for effective diagnostic technologies. The first case of COVID-19 was found in Dec 2019, by the end of Dec 2020, the count has surged to more than 90.3 million globally. This factor is expected to boost the growth of the market considerably. In an effort to maintain their position in market, prominent players are continuously launching several novel or complementary diagnostic methods. To access the Sample PDF of this research study, please request here: https://growthplusreports.com/inquiry/request-sample/molecular-diagnostics-market/7674 The report includes an in-depth study of the global market Molecular Diagnostics, where segments and sub-segments are analysed in quite a detail. This research will help players focus on high-growth segments and modify their business strategies if needed. The Diabetes Care Devices global market is segmented based on Products, Technology, and End Users. The regional segmentation research presented in the report provides players with valuable insights and data regarding key geographic markets such as North America, Europe, Asia Pacific, and the Rest of the World (RoW). Our researchers and analysts use reliable primary and secondary sources for research and data. Some of the prominent players operating in the global Molecular Diagnostics Market include ➢F. Hoffmann-La Roche Ltd ➢bioMerieux SA ➢Beckman Coulter ➢BD, Siemens Healthcare Private Limited ➢Grifols ➢S.A ➢Abbott Laboratories ➢Hologic ➢Danaher ➢QIAGEN Table of Contents 1. INTRODUCTION 1. Market Ecosystem 2. Geographic Scope

  2. 3. Timeline Under Consideration 1. Historical Years – 2018 & 2019 2. Base Year – 2020 3. Forecasted Years – 2021 to 2031 4. Currency Used in the Report 2. RESEARCH METHODOLOGY 1. Research Approach 2. Data Collection Methodology 3. Data Sources 1. Secondary Sources 2. Primary Sources 4. Market Estimation Approach 1. Bottom Up 2. Top Down 5. Market Forecasting Model 6. Limitations and Assumptions 3. PREMIUM INSIGHTS 1. Current Market Trend (COVID-19 Perspective) 2. Technological Advancements 3. Key Players & Their Competitive Positioning (2020) 4. MARKET DYNAMICS 1. Drivers 2. Restraints/Challenges 3. Opportunities 5. GLOBAL MOLECULAR DIAGNOSTICS MARKET – ANALYSIS & FORECAST, BY PRODUCT & SERVICES 1. Systems & Instruments 2. Assay Reagents & Kits 3. Software & Services 6. GLOBAL MOLECULAR DIAGNOSTICS MARKET – ANALYSIS & FORECAST, BY TECHNOLOGY 1. Polymerase Chain Reaction (PCR) 2. DNA Sequencing & Next-Generation Sequencing (NGS) 3. In Situ Hybridization 4. Microarrays 5. Others (Transcription Mediated Amplification, Mass Spectrometry etc.) 7. GLOBAL MOLECULAR DIAGNOSTICS MARKET – ANALYSIS & FORECAST, BY APPLICATION 1. Infectious disease 2. Oncology 3. Pharmacogenomics 4. Genetic Testing 5. Others (Neurological Disease, Cardiovascular Disease, etc.) 8. GLOBAL MOLECULAR DIAGNOSTICS MARKET – ANALYSIS & FORECAST, BY END USER 1. Hospitals

  3. 2. Academic Institutes & Research Centers 3. Clinical & Pathology Labs TOC Continued… Browse the full report now: https://growthplusreports.com/report/molecular-diagnostics- market/7674 About Us: Growth+Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association). Growth+ portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis, and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success. We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.

More Related